Avita Medical | Bienes



Assets Cambio Fecha
Adcock Ingram Holdings ZAR 8.74B 388.13M 2024-12
Celltrion KRW 20.96T 96.41B 2025-03
Clinuvel Pharmaceuticals AUD 231.12M 19.44M 2024-06
Cochlear AUD 2.79B 41M 2024-12
CSL USD 38.45B 425M 2024-12
Cspc Pharmaceutical CNY 44.39B 3.51B 2024-12
Dianthus Therapeutics USD 374.01M 19.76M 2024-12
Divis Laboratories Ltd 169.32B 13.46B 2025-03
Kangmei Pharma CNY 14.19B 63.4M 2024-09
Knight Therapeutics CAD 962.29M 16.93M 2024-09
Laboratorios Farma EUR 832.02M 25.3M 2024-12
Malin Corporation EUR 198.5M 70.1M 2024-12
Mayne Pharma AUD 1.14B 9.47M 2024-06
Medical Developments International AUD 65.33M 6.17M 2024-12
Nanosonics AUD 255.03M 17.69M 2024-12
Neuren Pharmaceuticals AUD 409.71M 181.55M 2024-12
Organigram Holdings CAD 479.21M 71.35M 2024-12
Pacific Edge NZD 50.85M 14.6M 2024-09
Paradigm Biopharmaceuticals AUD 35.36M 7.97M 2024-12
Pharma Mar EUR 333.5M 16.15M 2025-03
Polynovo AUD 108.72M 11.51M 2024-06
PYC Therapeutics AUD 68.23M 23.01M 2024-12
Qiagen NV USD 5.55B 144.25M 2025-03
Ramsay Health Care AUD 20.66B 237M 2024-12
ResMed USD 7.14B 81.08M 2024-12
Sartorius EUR 10.11B 9.3M 2025-03
Sino Biopharmaceutical CNY 65.41B 1.3B 2024-12
Telix Pharmaceuticals AUD 1.52B 770.47M 2024-12
Tilray USD 4.19B 70.11M 2024-11
Zz Pientze Pharmaceu 18.48B 944.93M 2025-03



Avita Medical Bienes - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Jun 2025.